LONDON--(BUSINESS WIRE)--BioBeats, the digital health and artificial intelligence business, has successfully completed a critical step in the development of its scientific approach to biometric detection and analysis for better workplace stress management with one of the UK’s leading health insurers, AXA PPP healthcare.
The study, which involved 60 AXA employees wearing activity trackers and using bespoke BioBeats smartphone apps for two months, focused on refining the health tech specialist’s machine learning algorithms for analysing and classifying daily activities and their correlation to psychological and physiological stress.
The undertaking evidences BioBeats’ commitment to developing innovative approaches to preventive healthcare using wearable sensors and artificial intelligence to generate outputs that enable employees to better understand and manage their stress and wellbeing. The Company is expected to advise on its other biometric pilots and artificial intelligence and machine learning technical advances over the coming weeks.
Rob Brougham, CEO of BioBeats said “The initial pilot study with AXA has taught us a lot about how to engage with employees effectively and is proving a real boon to the successful application of biometric tracking and pattern spotting algorithms to cost effective tools for monitoring and managing employee stress.”
Dr Gary Bolger, Chief Medical Officer for AXA PPP healthcare, said “We’re pleased to have helped BioBeats to undertake this preliminary study. If the findings can be used to develop of better tools for monitoring and managing stress, it should be of considerable benefit to employees – enabling them to deal more effectively with the pressures in their lives.”
BioBeatsBioBeats is a digital health and artificial intelligence company that specializes in creating easy-to-use corporate and personal wellness solutions. Its world-class team of scientists and designers includes renowned experts in AI, machine learning, wearables, cloud solutions and theoretical computer science. BioBeats solutions, based on years of research, provide insights into individual health and wellbeing by tracking data from wearable and smartphone sensors. Biometric and psychometric feedback is combined with unique machine learning algorithms to deliver personalized stress and productivity management tools based on clinically proven coaching techniques.
Following the launch of its consumer-facing app Hear and Now (recently featured in Apple App Store’ s Best New Apps, April 2016), the team now provides tools to foster wellness at scale, with bespoke corporate versions in active deployment. The company’ s corporate offering provides solutions to help employees privately control their own wellness through the use of wearables and data-driven coaching.
The AXA Group is a worldwide leader in insurance and asset management, with 166,000 employees serving 103 million clients in 64 countries. In 2015, IFRS revenues amounted to Euro 99.0 billion and IFRS underlying earnings to Euro 5.6 billion. AXA had Euro 1,363 billion assets under management as of December 31, 2015. In 2015 Interbrand ranked AXA the 1st insurance brand worldwide for the 7th consecutive year.
In the UK AXA operates through a number of business units including: AXA Wealth, AXA Insurance, AXA PPP healthcare, AXA Ireland and an independent distribution business Bluefin. AXA employs over 10,500 staff in the UK.
The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISN FR 0000120628 – Bloomberg: CS FP – Reuters: AXAF.PA). AXA’s American Depository Share is also quoted on the OTC QX platform under the ticker symbol AXAHY.
The AXA Group is included in the main international SRI indexes, such as Dow Jones Sustainability Index (DJSI) and FTSE4GOOD.
It is a founding member of the UN Environment Programme’s Finance Initiative (UNEP FI) Principles for Sustainable Insurance and a signatory of the UN Principles for Responsible Investment.